Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis

Autor: Sara McCurdy, Noboru Yamazaki, Yvonne Baumer, Stefan J. Halbherr, William A. Boisvert, Tina M. Weatherby, Nehal N. Mehta, Pascal Halbherr
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Apolipoprotein E
Male
General Physics and Astronomy
030204 cardiovascular system & hematology
chemistry.chemical_compound
Mice
0302 clinical medicine
Hyperlipidemia
lcsh:Science
Barrier function
Aorta
Cells
Cultured

Multidisciplinary
Forskolin
Chemistry
food and beverages
3. Good health
Femoral Artery
Lipoproteins
LDL

medicine.anatomical_structure
Carotid Arteries
Cholesterol
Female
lipids (amino acids
peptides
and proteins)

Rolipram
medicine.drug
medicine.medical_specialty
Endothelium
Science
Hyperlipidemias
Mice
Transgenic

Diet
High-Fat

General Biochemistry
Genetics and Molecular Biology

Article
Apolipoproteins E
03 medical and health sciences
Internal medicine
medicine
Animals
Humans
Colforsin
fungi
Endothelial Cells
General Chemistry
Sinus of Valsalva
medicine.disease
Atherosclerosis
Mice
Inbred C57BL

030104 developmental biology
Endocrinology
Liposomes
lcsh:Q
Endothelium
Vascular
Zdroj: Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Nature Communications
ISSN: 2041-1723
Popis: Endothelial cells (EC) play a key role in atherosclerosis. Although EC are in constant contact with low density lipoproteins (LDL), how EC process LDL and whether this influences atherogenesis, is unclear. Here we show that EC take up and metabolize LDL, and when overburdened with intracellular cholesterol, generate cholesterol crystals (CC). The CC are deposited on the basolateral side, and compromise endothelial function. When hyperlipidemic mice are given a high fat diet, CC appear in aortic sinus within 1 week. Treatment with cAMP-enhancing agents, forskolin/rolipram (F/R), mitigates effects of CC on endothelial function by not only improving barrier function, but also inhibiting CC formation both in vitro and in vivo. A proof of principle study using F/R incorporated into liposomes, designed to target inflamed endothelium, shows reduced atherosclerosis and CC formation in ApoE −/− mice. Our findings highlight an important mechanism by which EC contribute to atherogenesis under hyperlipidemic conditions.
Atherosclerosis is characterized by subendothelial lipid retention believed to be the result of endothelial trancytosis. Here, the authors show that endothelium can take up and process LDL, generating cholesterol crystals that are deposited on the basolateral side of the cells, causing their dysfunction that can be prevented by forskolin/rolipram treatment.
Databáze: OpenAIRE